Please login to the form below

Not currently logged in


This page shows the latest Aprecia news and features for those working in and with pharma, biotech and healthcare.

3D printed epilepsy drug launched in the US

3D printed epilepsy drug launched in the US

Aprecia’s Spritam is now available as a prescription drug. The first ever drug manufactured using 3D printing technology is now available to US patients with epilepsy. ... Aprecia Pharmaceutical's Spritam was approved by the FDA in August last year,

Latest news

  • Printable pharma Printable pharma

    Spritam is designed to fill a need for patients who struggle with their current medication experience,” commented Don Wetherhold, Aprecia's chief executive. ... This is the first in a line of central nervous system products Aprecia plans to introduce

  • FDA approves world’s first 3D printed drug FDA approves world’s first 3D printed drug

    The drug Spritam (levetiracetam), from Aprecia Pharmaceuticals, has been given the green light from the US regulator as an adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and ... experience. "This is the first in a line

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...